Targeted therapies: HER2-positive breast cancer-sifting through many good options
- PMID: 23629473
- DOI: 10.1038/nrclinonc.2013.72
Targeted therapies: HER2-positive breast cancer-sifting through many good options
Comment on
-
Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.J Clin Oncol. 2013 Jun 1;31(16):1947-53. doi: 10.1200/JCO.2011.40.5241. Epub 2013 Mar 18. J Clin Oncol. 2013. PMID: 23509322 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
